Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 513 Records) |
| Query Trace: Neoplasms and PALB2[original query] |
|---|
| PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer. Cancers 2023 9 15 (17): . Henriett Butz, Petra Nagy, János Papp, Anikó Bozsik, Vince Kornél Grolmusz, Tímea Pócza, Edit Oláh, Attila Pató |
| Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease. Annals of surgical oncology 2023 9 . Jennifer Q Zhang, Carlos Henrique Dos Anjos, Varadan Sevilimedu, Angelena Crown, Kimberly A Amoroso, Melissa L Pilewskie, Mark E Robson, Mary L Gemigna |
| Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. Gynecologic oncology 2023 8 177 72-85. Priyanka Narayan, Muhammad Danyal Ahsan, Emily M Webster, Luiza Perez, Sarah R Levi, Benedict Harvey, Isabel Wolfe, Shanice Beaumont, Jesse T Brewer, Drew Siegel, Charlene Thomas, Paul Christos, Andy Hickner, Eloise Chapman-Davis, Evelyn Cantillo, Kevin Holcomb, Ravi N Sharaf, Melissa K Fr |
| Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 2023 8 7 e2200695. Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke Lucassen, Nadine M Tung, Claudine Isaa |
| Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. Journal of medical genetics 2023 8 . Nathalia de Angelis de Carvalho, Karina Miranda Santiago, Joyce Maria Lisboa Maia, Felipe D'Almeida Costa, Maria Nirvana Formiga, Diogo Cordeiro de Queiroz Soares, Daniele Paixão, Celso Abdon Lopes de Mello, Cecilia Maria Lima da Costa, José Claudio Casali da Rocha, Barbara Rivera, Dirce Maria Carraro, Giovana Tardin Torrez |
| Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis. Genes 2023 8 14 (8): . Matvey M Tsyganov, Sofia S Sorokovikova, Elizaveta A Lutzkaya, Marina K Ibragimo |
| Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer. Genes 2023 8 14 (8): . Antonella Turchiano, Marilidia Piglionica, Stefania Martino, Rosanna Bagnulo, Antonella Garganese, Annunziata De Luisi, Stefania Chirulli, Matteo Iacoviello, Michele Stasi, Ornella Tabaku, Eleonora Meneleo, Martina Capurso, Silvia Crocetta, Simone Lattarulo, Yevheniia Krylovska, Patrizia Lastella, Cinzia Forleo, Alessandro Stella, Nenad Bukvic, Cristiano Simone, Nicoletta Res |
| The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic. Current issues in molecular biology 2023 8 45 (8): 6383-6394. Airat Bilyalov, Sergey Nikolaev, Anastasiia Danishevich, Igor Khatkov, Komron Makhmudov, Zhainagul Isakova, Nurbek Bakirov, Ernis Omurbaev, Alena Osipova, Ramaldan Ramaldanov, Elena Shagimardanova, Andrey Kiyasov, Oleg Gusev, Natalia Boduno |
| Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
| Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficien cy in Pancreatic Acinar Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 8 JCO2300561. Diana Mandelker, Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu, Andrea Gazzo, Donna Wong, Zarina Yelskaya, Vikas Rai, Joshua Somar, Silvana Ostafi, Nikita Mehta, Ciyu Yang, Yirong Li, David N Brown, Edaise M da Silva, Xin Pei, Irina Linkov, Panieh Terraf, Maksym Misyura, Ozge Ceyhan-Birsoy, Marc Ladanyi, Michael Berger, Fresia Pareja, Zsofia Stadler, Kenneth Offit, Nadeem Riaz, Wungki Park, Joanne Chou, Marinela Capanu, Maria Koehler, Ezra Rosen, Eileen M O'Reilly, Jorge S Reis-Fil |
| Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nature genetics 2023 8 . Naomi Wilcox, Martine Dumont, Anna González-Neira, Sara Carvalho, Charles Joly Beauparlant, Marco Crotti, Craig Luccarini, Penny Soucy, Stéphane Dubois, Rocio Nuñez-Torres, Guillermo Pita, Eugene J Gardner, Joe Dennis, M Rosario Alonso, Nuria Álvarez, Caroline Baynes, Annie Claude Collin-Deschesnes, Sylvie Desjardins, Heiko Becher, Sabine Behrens, Manjeet K Bolla, Jose E Castelao, Jenny Chang-Claude, Sten Cornelissen, Thilo Dörk, Christoph Engel, Manuela Gago-Dominguez, Pascal Guénel, Andreas Hadjisavvas, Eric Hahnen, Mikael Hartman, Belén Herráez, , Audrey Jung, Renske Keeman, Marion Kiechle, Jingmei Li, Maria A Loizidou, Michael Lush, Kyriaki Michailidou, Mihalis I Panayiotidis, Xueling Sim, Soo Hwang Teo, Jonathan P Tyrer, Lizet E van der Kolk, Cecilia Wahlström, Qin Wang, John R B Perry, Javier Benitez, Marjanka K Schmidt, Rita K Schmutzler, Paul D P Pharoah, Arnaud Droit, Alison M Dunning, Anders Kvist, Peter Devilee, Douglas F Easton, Jacques Sima |
| A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer. Journal of cancer research and clinical oncology 2023 8 . Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming C |
| Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes. Journal of translational medicine 2023 7 21 (1): 446. Xiaohao Ruan, Da Huang, Jingyi Huang, James Hok-Leung Tsu, Rong |
| Germline mutations in 32 cancer susceptibility genes by Next-Generation Sequencing among breast cancer patients. Oncology 2023 7 . Yu Yang, Chang Liu, Zhong-Ling Zhuo, Fei Xie, Ke Wang, Shu Wang, Xiao-Tao Zh |
| Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants. medRxiv : the preprint server for health sciences 2023 7 . Thanthirige Lakshika M Ruberu, Danielle Braun, Giovanni Parmigiani, Swati Bisw |
| Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers. The Journal of surgical research 2023 7 291 388-395. Alison C Coogan, Lilia G Lunt, Sarah S Keshwani, Olivia Sandhu, Yanyu Zhang, Cristina O'Donoghue, Andrea Madrigra |
| Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients. European journal of human genetics : EJHG 2023 7 . Christopher Schroeder, Ulrike Faust, Luisa Krauße, Alexandra Liebmann, Michael Abele, German Demidov, Leon Schütz, Olga Kelemen, Alexandra Pohle, Silja Gauß, Marc Sturm, Cristiana Roggia, Monika Streiter, Rebecca Buchert, Sorin Armenau-Ebinger, Dominik Nann, Rudi Beschorner, Rupert Handgretinger, Martin Ebinger, Peter Lang, Ursula Holzer, Julia Skokowa, Stephan Ossowski, Tobias B Haack, Ulrike A Mau-Holzmann, Andreas Dufke, Olaf Riess, Ines B Brec |
| Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 7 . Joanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, Lauren R Teras, Alpa V Patel, Chunling Hu, Siddhartha Yadav, Fergus J Couch, Shelley S Tworog |
| The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas B Karasic, Charles Schneider, Erica L Carpenter, Katherine Nathanson, Susan M Domchek, Kim A Rei |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort. Cancers 2023 7 15 (13): . Ahmed Bouras, Souhir Guidara, Mélanie Leone, Adrien Buisson, Tanguy Martin-Denavit, Sophie Dussart, Christine Lasset, Sophie Giraud, Marie-Noëlle Bonnet-Dupeyron, Zine-Eddine Kherraf, Damien Sanlaville, Sandra Fert-Ferrer, Marine Lebrun, Valerie Bonadona, Alain Calender, Nadia Boutry-Kry |
| Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients. Genes, chromosomes & cancer 2023 7 . Paula Paulo, Marta Cardoso, Andreia Brandão, Pedro Pinto, Ariane Falconi, Manuela Pinheiro, Nuno Cerveira, Rui Silva, Catarina Santos, Carla Pinto, Ana Peixoto, Sofia Maia, Manuel R Teixei |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. Translational lung cancer research 2023 7 12 (6): 1236-1244. Ju-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, Jennifer J D Morrissette, Katherine L Nathanson, Roger B Cohen, Jason N Rosenba |
| p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression. International journal of molecular sciences 2023 6 24 (12): . Luiza Steffens Reinhardt, Kira Groen, Alexandre Xavier, Kelly A Avery-Kiej |
| Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC)Unveils New Actionable Genomic Aberrations in PACC. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Vaia Florou, Andrew Elliott, Matthew H Bailey, David Stone, Kajsa Affolter, Heloisa P Soares, Chris Nevala-Plagemann, Courtney Scaife, Phillip Walker, W Michael Korn, Emil Lou, Rachna T Shroff, Peter J Hosein, Ignacio Garrido-Lagu |
| Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel. Oncotarget 2023 6 14 580-594. Musa AlHarbi, Nahla Ali Mobark, Wael Abdel Rahman AlJabarat, Hadeel ElBardis, Ebtehal AlSolme, Abdullah Bany Hamdan, Ali H AlFakeeh, Fatimah AlMushawah, Fawz AlHarthi, Abdullah A AlSharm, Ali Abdullah O Balbaid, Naji AlJohani, Alicia Y Zhou, Heather A Robinson, Saleh A Alqahtani, Malak Abedalthaga |
| Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study. European journal of cancer (Oxford, England : 1990) 2023 6 188 183-191. Agostino Bucalo, Giulia Conti, Virginia Valentini, Carlo Capalbo, Alessandro Bruselles, Marco Tartaglia, Bernardo Bonanni, Daniele Calistri, Anna Coppa, Laura Cortesi, Giuseppe Giannini, Viviana Gismondi, Siranoush Manoukian, Livia Manzella, Marco Montagna, Paolo Peterlongo, Paolo Radice, Antonio Russo, Maria Grazia Tibiletti, Daniela Turchetti, Alessandra Viel, Ines Zanna, Domenico Palli, Valentina Silvestri, Laura Otti |
| Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. Biomedicines 2023 5 11 (5): . Andreea C?tan?, Adrian P Trifa, Patriciu A Achimas-Cadariu, Gabriela Bolba-Morar, Carmen Lisencu, Eniko Kutasi, Vlad F Chelaru, Maximilian Muntean, Daniela L Martin, Nicoleta Z Antone, Bogdan Fetica, Florina Pop, Mariela S Milita |
| Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Scientific reports 2023 5 13 (1): 8536. Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne-Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkels |
| Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases. Pathology, research and practice 2023 5 247 154514. M Arranz-Ledo, E Lastra, L Abella, R Ferreira, M Orozco, L Hernández, N Martínez, M Infante, M Dur |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: